Literature DB >> 32326728

Significance of a positive sentinel lymph node biopsy in staging for distant metastasis in breast cancer: are current guidelines relevant?

Tje Hubbard1, C Ives1.   

Abstract

INTRODUCTION: In breast cancer, early identification of distant metastasis changes management. Current guidelines recommend radiological staging in patients with a preoperative positive axilla; no guidelines address a preoperative negative axilla with subsequent positive sentinel lymph node biopsy. This study investigates whether current guidelines adequately identify distant metastasis in a positive sentinel lymph node biopsy population that had radiological staging.
MATERIALS AND METHODS: Patients diagnosed with primary breast cancer between 1 January 2013 and 1 October 2017 with a positive sentinel lymph node biopsy and subsequent radiological staging from a single unit were included. A systematic search identified relevant guideline criteria, against which patients were audited.
RESULTS: A total of 330 patients with positive sentinel lymph node biopsy were identified; 227 (69%) had radiological staging postoperatively with computed tomography (5.3%), bone scan (2.6%) and both (92%) which identified 8/227 (3.5%) patients had distant metastasis. Patients with distant metastasis (DMp) compared with those without distant metastasis (NDMp) were associated with poorly differentiated tumours (DMp 62% vs NDMp 28%; p = 0.037), high-grade ductal carcinoma in situ (DMp 75% vs NDMp 39%; p = 0.043) and increased mean invasive tumour size (DMp 37mm vs NDMp 24mm; p = 0.014). Binomial logistic regression did not identify any characteristics to predict distant metastasis in staged patients (chi-squared p = 0.162). Two guidelines used postoperative results to inform radiological staging decision; 68/227 (30%) of staged patients met these guideline criteria, five of eight patients with distant metastasis did not meet current guideline criteria for radiological staging. DISCUSSION: Over 50% of patients with distant metastasis did not meet current guideline criteria for radiological staging and would have remained undiagnosed if current guidelines were followed. This study had an acceptable detection rate of 3.5% for distant metastasis. We therefore recommend radiological staging in all patients with positive sentinel lymph node biopsy.

Entities:  

Keywords:  Breast neoplasms; Sentinel lymph node biopsy; metastasis

Mesh:

Year:  2020        PMID: 32326728      PMCID: PMC7388966          DOI: 10.1308/rcsann.2020.0065

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  19 in total

1.  Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis.

Authors:  E F Solomayer; I J Diel; G C Meyberg; C Gollan; G Bastert
Journal:  Breast Cancer Res Treat       Date:  2000-02       Impact factor: 4.872

2.  Value analysis of postoperative staging imaging for asymptomatic, early-stage breast cancer: implications of clinical variation on utility and cost.

Authors:  Andrew C Pellet; Mujde Z Erten; Ted A James
Journal:  Am J Surg       Date:  2015-11-03       Impact factor: 2.565

3.  Age at diagnosis and distant metastasis in breast cancer--a surprising inverse relationship.

Authors:  A Purushotham; E Shamil; M Cariati; O Agbaje; A Muhidin; C Gillett; A Mera; K Sivanadiyan; M Harries; R Sullivan; S E Pinder; H Garmo; L Holmberg
Journal:  Eur J Cancer       Date:  2014-04-23       Impact factor: 9.162

4.  Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases.

Authors:  C L Carter; C Allen; D E Henson
Journal:  Cancer       Date:  1989-01-01       Impact factor: 6.860

Review 5.  Breast cancer metastasis: markers and models.

Authors:  Britta Weigelt; Johannes L Peterse; Laura J van 't Veer
Journal:  Nat Rev Cancer       Date:  2005-08       Impact factor: 60.716

6.  Baseline staging tests in primary breast cancer: a practice guideline.

Authors:  R E Myers; M Johnston; K Pritchard; M Levine; T Oliver
Journal:  CMAJ       Date:  2001-05-15       Impact factor: 8.262

7.  Metastatic behavior of breast cancer subtypes.

Authors:  Hagen Kennecke; Rinat Yerushalmi; Ryan Woods; Maggie Chon U Cheang; David Voduc; Caroline H Speers; Torsten O Nielsen; Karen Gelmon
Journal:  J Clin Oncol       Date:  2010-05-24       Impact factor: 44.544

Review 8.  Sentinel lymph node micrometastasis in human breast cancer: an update.

Authors:  Mohamed Salhab; Neill Patani; Kefah Mokbel
Journal:  Surg Oncol       Date:  2011-07-23       Impact factor: 3.279

9.  Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial.

Authors:  David N Krag; Stewart J Anderson; Thomas B Julian; Ann M Brown; Seth P Harlow; Takamaru Ashikaga; Donald L Weaver; Barbara J Miller; Lynne M Jalovec; Thomas G Frazier; R Dirk Noyes; André Robidoux; Hugh M C Scarth; Denise M Mammolito; David R McCready; Eleftherios P Mamounas; Joseph P Costantino; Norman Wolmark
Journal:  Lancet Oncol       Date:  2007-10       Impact factor: 41.316

10.  Breast cancer statistics, 2017, racial disparity in mortality by state.

Authors:  Carol E DeSantis; Jiemin Ma; Ann Goding Sauer; Lisa A Newman; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2017-10-03       Impact factor: 508.702

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.